- Home
- MREO
MREO
Mereo BioPharma Group plc
as 12-20-2024 4:00pm EST
| Founded: | 2015 | Country: | United Kingdom |
| Employees: | N/A | City: | LONDON |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $7.40 | AVG Volume (30 days): | 939.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.03 - $5.02 | Next Earning Date: | 02-13-2025 |
| Revenue: | $1,000,000 | Revenue Growth: | -88.89% |
| Revenue Growth (this year): | -3.01% | Revenue Growth (next year): | 9.44% |
Latest Mereo BioPharma Group plc News
MREO Breaking Stock News: Dive into MREO Ticker-Specific Updates for Smart Investing
TipRanks
15 days ago
Mereo BioPharma initiated with a Buy at Jefferies
GuruFocus.com
16 days ago
Mereo BioPharma Stock Climbs Following Jefferies' Buy Rating, Upside Potential of 89%
MT Newswires
16 days ago
Mereo BioPharma Shares Rise After Jefferies Begins Coverage at Buy
MT Newswires
16 days ago
Jefferies Initiates Mereo BioPharma at Buy With $7 Price Target
GlobeNewswire
a month ago
Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference
GlobeNewswire
a month ago
Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Insider Monkey
2 months ago
Is Mereo BioPharma Group (MREO) the Hottest Penny Stock to Invest in According to Hedge Funds?
Insider Monkey
3 months ago
Mereo BioPharma Group plc (MREO): A Bull Case Theory
Compare MREO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MREO Mereo BioPharma Group plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.